Benzinga Pro Headlines
Headlines
Needham Maintains Buy on Ciena, Raises Price Target to $240
Needham analyst Ryan Koontz maintains Ciena (NYSE:CIEN) with a Buy and raises the price target from $130 to $240.
BTIG Maintains Buy on Flutter Entertainment, Raises Price Target to $281
BTIG analyst Clark Lampen maintains Flutter Entertainment (NYSE:FLUT) with a Buy and raises the price target from $271 to $281.
BTIG Maintains Buy on DraftKings, Raises Price Target to $45
BTIG analyst Clark Lampen maintains DraftKings (NASDAQ:DKNG) with a Buy and raises the price target from $42 to $45.
Needham Maintains Buy on SentinelOne, Lowers Price Target to $21
Needham analyst Mike Cikos maintains SentinelOne (NYSE:S) with a Buy and lowers the price target from $23 to $21.
BTIG Reiterates Buy on PVH, Maintains $100 Price Target
BTIG analyst Robert Drbul reiterates PVH (NYSE:PVH) with a Buy and maintains $100 price target.
BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $103
BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $100 to $103.
BTIG Reiterates Buy on Mid-America Apartment, Maintains $160 Price Target
BTIG analyst Michael Gorman reiterates Mid-America Apartment (NYSE:MAA) with a Buy and maintains $160 price target.
BTIG Reiterates Buy on Denali Therapeutics, Maintains $32 Price Target
BTIG analyst Thomas Shrader reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $32 price target.
Needham Reiterates Buy on Robinhood Markets, Maintains $145 Price Target
Needham analyst John Todaro reiterates Robinhood Markets (NASDAQ:HOOD) with a Buy and maintains $145 price target.
Needham Reiterates Buy on Crocs, Maintains $100 Price Target
Needham analyst Tom Nikic reiterates Crocs (NASDAQ:CROX) with a Buy and maintains $100 price target.
Reuters Reported Saab, Airbus Co-operate On Unmanned Fighter Technology
Needham Maintains Buy on Cooper Companies, Raises Price Target to $100
Needham analyst David Saxon maintains Cooper Companies (NASDAQ:COO) with a Buy and raises the price target from $94 to $100.
Needham Reiterates Hold on Docusignto Hold
Needham analyst Scott Berg reiterates Docusign (NASDAQ:DOCU) from Hold to Hold.
Small Cap Consumer Research Maintains Buy on Build-A-Bear Workshop, Lowers Price Target to $65
Small Cap Consumer Research analyst Eric M Beder maintains Build-A-Bear Workshop (NYSE:BBW) with a Buy and lowers the price target from $75 to $65.
Needham Reiterates Buy on BETA Technologies, Maintains $34 Price Target
Needham analyst Chris Pierce reiterates BETA Technologies (NYSE:BETA) with a Buy and maintains $34 price target.
Tuniu Q3 EPS $0.01 Down From $0.06 YoY, Sales $28.384M Up From $26.505M YoY
Piper Sandler Maintains Overweight on ServiceTitan, Lowers Price Target to $140
Piper Sandler analyst Hannah Rudoff maintains ServiceTitan (NASDAQ:TTAN) with a Overweight and lowers the price target from $155 to $140.
Reported Earlier, Grupo Aeroportuario Del Pacifico Reports November 2025 Passenger Traffic Down 2.0% YoY
Reported Earlier, Innovent Biologics Announces Closing Of Global Strategic Partnership With Takeda For IBI363 And IBI343, With Option On IBI3001, Including $1.2B Upfront And Up To $11.4B Total Deal Value
Reported Earlier, Ascentage Pharma Says US FDA And EMA Clear Global Registrational Phase III POLARIS-1 Of Olverembatinib Plus Chemotherapy In First-Line Ph+ ALL, With ASH 2025 Data Highlighting ~65% MRD Negativity
Reported Earlier, Biocytogen-Licensed IDEAYA IDE034 Bispecific ADC Wins FDA IND Clearance, Paving Way For Phase 1 Trial And Q1 2026 Patient Enrollment
Reported Earlier, Hudson Pacific Sells 284,000-Square-Foot Element LA For $150M Plus $81M Lease Termination
Reported Earlier, Hudson Pacific Properties Updates Q4 2025 FFO Outlook To $0.15–$0.25 After 1-For-7 Reverse Split, Element LA Sale, And $206.3M CMBS Repayment
Reported Earlier, CEA Industries Says Shareholders Need Not Take Action As Company Re-Affirms Goal To Become The World's Largest BNB Treasury Company
Reported Earlier, Protara Prices $75M Underwritten Public Offering Of 13,043,479 Common Stock Shares At $5.75 Per Share
Reported Earlier, Symbotic Announces Pricing Of 10M Share Class A Common Stock Primary And Secondary Offering At $55.00 Per Share
Reported Earlier, Canadian Natural Resources Prices C$1.65B Medium-Term Notes Offering; Issues 3, 5 And 10 Year Notes With 3.30%, 3.75% And 4.55% Coupons
Fastly, Prices Upsized $160M 0% Convertible Senior Notes Due 2030; Sets $15.26 Conversion Price And $23.04 Capped Call Cap Price
Reported Earlier, Japan Household Spending (YoY) For October -3.0% Vs. 1.1% Est.; 1.8% Prior
Reported Earlier, India Interest Rate Decision 5.25% Vs. 5.25% Est.; 5.50% Prior
Reported Earlier, Japan Household Spending (MoM) For October -3.5% Vs. 0.7% Est.; -0.7% Prior
'National Economic Council Director Kevin Hassett Says Fed Should Cut Rates, Predicts 25 Basis Points' - Bloomberg News
FDA Approves First CAR T-Cell Therapy For Marginal Zone Lymphoma In The US; Approved A New Indication For Breyanzi
Titan International Appoints Tony Eheli As Senior Vice President And CFO
'MUFG Seeks to Extend Morgan Stanley Ties to Asset Management Business' - Bloomberg
'Warner Bros. Explores Licensing Batman Rides to Universal Parks' - Bloomberg
Apple Announces Jennifer Newstead Will Join As Senior Vice President And Become General Counsel In Mar. 2026
'Data Center Firm Fluidstack In Talks For $7 Billion Valuation; Google In Talks About Possible Investment, Person Familiar Says' - Bloomberg News
World Kinect Corporation Announces Additional $150M Share Repurchase Authorization.
Capricor Therapeutics Announces Proposed Public Offering Of Common Stock; Terms Not Disclosed
Macquarie Maintains Neutral on Snowflake, Raises Price Target to $250
Macquarie analyst Steve Koenig maintains Snowflake (NYSE:SNOW) with a Neutral and raises the price target from $235 to $250.
'PepsiCo Nears Settlement With Activist Investor Elliott' - WSJ Exclusive
https://www.wsj.com/business/deals/pepsico-nears-settlement-with-activist-investor-elliott-dbda9a2a
TD Securities Upgrades Royal Bank of Canada to Buy, Raises Price Target to C$246
TD Securities analyst Mario Mendonca upgrades Royal Bank of Canada (TSX:RY) from Hold to Buy and raises the price target from C$215 to C$246.
Scotiabank Maintains Sector Outperform on National Bank of Canada, Raises Price Target to C$184
Scotiabank analyst Mike Rizvanovic maintains National Bank of Canada (TSX:NA) with a Sector Outperform and raises the price target from C$166 to C$184.
Scotiabank Maintains Sector Outperform on Descartes Systems Group, Lowers Price Target to $115
Scotiabank analyst Kevin Krishnaratne maintains Descartes Systems Group (NASDAQ:DSGX) with a Sector Outperform and lowers the price target from $127 to $115.
Scotiabank Maintains Sector Perform on Canfor Pulp Products, Lowers Price Target to C$0.5
Scotiabank analyst Ben Isaacson maintains Canfor Pulp Products (TSX:CFX) with a Sector Perform and lowers the price target from C$0.55 to C$0.5.
Scotiabank Maintains Sector Perform on Bristol-Myers Squibb, Raises Price Target to $53
Scotiabank analyst Louise Chen maintains Bristol-Myers Squibb (NYSE:BMY) with a Sector Perform and raises the price target from $45 to $53.
Scotiabank Maintains Sector Outperform on Merck & Co, Raises Price Target to $120
Scotiabank analyst Louise Chen maintains Merck & Co (NYSE:MRK) with a Sector Outperform and raises the price target from $105 to $120.
'US senators seek to block Nvidia sales of advanced chips to China' - Financial Times
https://www.ft.com/content/0e4e4799-b340-4cee-bdbc-6a6325f77eac
Maxim Group Maintains Buy on Capricor Therapeutics, Raises Price Target to $50
Maxim Group analyst Jason McCarthy maintains Capricor Therapeutics (NASDAQ:CAPR) with a Buy and raises the price target from $25 to $50.
Barclays Maintains Overweight on TJX Companies, Raises Price Target to $172
Barclays analyst Adrienne Yih maintains TJX Companies (NYSE:TJX) with a Overweight and raises the price target from $168 to $172.
Barclays Maintains Equal-Weight on UiPath, Raises Price Target to $16
Barclays analyst Raimo Lenschow maintains UiPath (NYSE:PATH) with a Equal-Weight and raises the price target from $14 to $16.
Jefferies Maintains Buy on Five Below, Raises Price Target to $215
Jefferies analyst Randal Konik maintains Five Below (NASDAQ:FIVE) with a Buy and raises the price target from $185 to $215.
Jefferies Maintains Buy on Macy's, Raises Price Target to $26
Jefferies analyst Ashley Helgans maintains Macy's (NYSE:M) with a Buy and raises the price target from $18.5 to $26.
Jefferies Maintains Buy on Axogen, Raises Price Target to $36
Jefferies analyst Michael Sarcone maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $29 to $36.
Freedom Capital Markets Upgrades Global Water Resources to Buy, Announces $9.6 Price Target
Freedom Capital Markets analyst Matvey Tayts upgrades Global Water Resources (NASDAQ:GWRS) from Hold to Buy and announces $9.6 price target.
DA Davidson Maintains Buy on Microsoft, Maintains $650 Price Target
DA Davidson analyst Gil Luria maintains Microsoft (NASDAQ:MSFT) with a Buy and maintains $650 price target.
DA Davidson Maintains Neutral on Guidewire Software, Maintains $250 Price Target
DA Davidson analyst Peter Heckmann maintains Guidewire Software (NYSE:GWRE) with a Neutral and maintains $250 price target.
DA Davidson Maintains Neutral on GitLab, Maintains $45 Price Target
DA Davidson analyst Lucky Schreiner maintains GitLab (NASDAQ:GTLB) with a Neutral and maintains $45 price target.
DA Davidson Maintains Neutral on Thor Industries, Maintains $102 Price Target
DA Davidson analyst Griffin Bryan maintains Thor Industries (NYSE:THO) with a Neutral and maintains $102 price target.
DA Davidson Maintains Neutral on Grocery Outlet Holding, Maintains $15 Price Target
DA Davidson analyst Michael Baker maintains Grocery Outlet Holding (NASDAQ:GO) with a Neutral and maintains $15 price target.
DA Davidson Maintains Neutral on Costco Wholesale, Maintains $1000 Price Target
DA Davidson analyst Michael Baker maintains Costco Wholesale (NASDAQ:COST) with a Neutral and maintains $1000 price target.
DA Davidson Maintains Neutral on Asana, Lowers Price Target to $15
DA Davidson analyst Lucky Schreiner maintains Asana (NYSE:ASAN) with a Neutral and lowers the price target from $17 to $15.
'Paramount Raises Concerns About Netflix's Bid for Warner Bros. Discovery' - The Wall Street Journal Exclusive
Canaccord Genuity Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $1057
Canaccord Genuity analyst John Newman maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target from $850 to $1057.
Canaccord Genuity Maintains Buy on Aeva Technologies, Maintains $24 Price Target
Canaccord Genuity analyst George Gianarikas maintains Aeva Technologies (NASDAQ:AEVA) with a Buy and maintains $24 price target.
Chardan Capital Maintains Buy on uniQure, Maintains $53 Price Target
Chardan Capital analyst Daniil Gataulin maintains uniQure (NASDAQ:QURE) with a Buy and maintains $53 price target.
'Target Tests New Models for Next-Day Delivery' - The Wall Street Journal Exclusive
https://www.wsj.com/articles/target-tests-new-models-for-next-day-delivery-463adbe7
Citigroup Maintains Neutral on Macy's, Raises Price Target to $24
Citigroup analyst Paul Lejuez maintains Macy's (NYSE:M) with a Neutral and raises the price target from $19 to $24.
Citigroup Maintains Neutral on Five Below, Raises Price Target to $175
Citigroup analyst Paul Lejuez maintains Five Below (NASDAQ:FIVE) with a Neutral and raises the price target from $150 to $175.
'AI Cloud Provider Aiding Google's Chip Push Is in Talks to Raise $700 Million' - The Information
Citigroup Maintains Buy on Dollar Tree, Raises Price Target to $132
Citigroup analyst Paul Lejuez maintains Dollar Tree (NASDAQ:DLTR) with a Buy and raises the price target from $124 to $132.
Citigroup Maintains Neutral on Lineage, Lowers Price Target to $38
Citigroup analyst Nick Joseph maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $39 to $38.
Citigroup Maintains Neutral on Alexandria Real Estate, Lowers Price Target to $52
Citigroup analyst Nick Joseph maintains Alexandria Real Estate (NYSE:ARE) with a Neutral and lowers the price target from $61 to $52.
Citigroup Maintains Neutral on Marsh & McLennan Cos, Lowers Price Target to $201
Citigroup analyst Matthew Heimermann maintains Marsh & McLennan Cos (NYSE:MMC) with a Neutral and lowers the price target from $211 to $201.
Citigroup Maintains Neutral on Adobe, Lowers Price Target to $366
Citigroup analyst Tyler Radke maintains Adobe (NASDAQ:ADBE) with a Neutral and lowers the price target from $400 to $366.
Roth Capital Maintains Neutral on Thor Industries, Raises Price Target to $97
Roth Capital analyst Scott Stember maintains Thor Industries (NYSE:THO) with a Neutral and raises the price target from $93 to $97.
Roth Capital Reinstates Buy on Evolution Petroleum, Announces $5 Price Target
Roth Capital analyst Nick Pope reinstates Evolution Petroleum (AMEX:EPM) with a Buy and announces $5 price target.
Citigroup Maintains Buy on Oracle, Lowers Price Target to $375
Citigroup analyst Tyler Radke maintains Oracle (NYSE:ORCL) with a Buy and lowers the price target from $415 to $375.
CDC Vaccine Panel Defers Vote On Hepatitis B Recommendations Until Friday
https://www.youtube.com/watch?v=Fdk_-WFoDuw
Truist Securities Maintains Hold on Ncino, Lowers Price Target to $27
Truist Securities analyst Terry Tillman maintains Ncino (NASDAQ:NCNO) with a Hold and lowers the price target from $32 to $27.
Citigroup Maintains Buy on CrowdStrike Holdings, Raises Price Target to $595
Citigroup analyst Fatima Boolani maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and raises the price target from $575 to $595.
Truist Securities Maintains Buy on Salesforce, Lowers Price Target to $380
Truist Securities analyst Terry Tillman maintains Salesforce (NYSE:CRM) with a Buy and lowers the price target from $400 to $380.
Truist Securities Maintains Hold on Five Below, Raises Price Target to $179
Truist Securities analyst Scot Ciccarelli maintains Five Below (NASDAQ:FIVE) with a Hold and raises the price target from $168 to $179.
Raymond James Upgrades Descartes Systems Group to Outperform, Announces $118 Price Target
Raymond James analyst Steven Li upgrades Descartes Systems Group (NASDAQ:DSGX) from Market Perform to Outperform and announces $118 price target.
Macquarie Maintains Neutral on Salesforce, Raises Price Target to $265
Macquarie analyst Steve Koenig maintains Salesforce (NYSE:CRM) with a Neutral and raises the price target from $250 to $265.
Oppenheimer Maintains Outperform on Agilysys, Raises Price Target to $140
Oppenheimer analyst Brian Schwartz maintains Agilysys (NASDAQ:AGYS) with a Outperform and raises the price target from $130 to $140.
Oppenheimer Maintains Outperform on Pharvaris, Raises Price Target to $50
Oppenheimer analyst Justin Kim maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $44 to $50.
Oppenheimer Initiates Coverage On Ascentage Pharma Group with Outperform Rating, Announces Price Target of $45
Oppenheimer analyst Matthew Biegler initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Outperform rating and announces Price Target of $45.
Barrington Research Maintains Outperform on HealthEquity, Maintains $125 Price Target
Barrington Research analyst Alexander Paris maintains HealthEquity (NASDAQ:HQY) with a Outperform and maintains $125 price target.
Northland Capital Markets Maintains Market Perform on Salesforce, Raises Price Target to $267
Northland Capital Markets analyst Nehal Chokshi maintains Salesforce (NYSE:CRM) with a Market Perform and raises the price target from $264 to $267.
D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.
Morgan Stanley Maintains Overweight on Kyverna Therapeutics, Raises Price Target to $25
Morgan Stanley analyst Michael Ulz maintains Kyverna Therapeutics (NASDAQ:KYTX) with a Overweight and raises the price target from $20 to $25.
Lake Street Maintains Buy on Axogen, Raises Price Target to $40
Lake Street analyst Frank Takkinen maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $30 to $40.
Barrington Research Initiates Coverage On Phoenix Education with Outperform Rating, Announces Price Target of $45
Barrington Research analyst Alexander Paris initiates coverage on Phoenix Education (NYSE:PXED) with a Outperform rating and announces Price Target of $45.
Lake Street Maintains Buy on Inotiv, Lowers Price Target to $3
Lake Street analyst Frank Takkinen maintains Inotiv (NASDAQ:NOTV) with a Buy and lowers the price target from $5 to $3.
CNBC Halftime Report Final Trades: Rocket Companies, American Express Company, SLB, Parker-Hannifin
Goldman Sachs Maintains Buy on Five Below, Raises Price Target to $188
Goldman Sachs analyst Kate McShane maintains Five Below (NASDAQ:FIVE) with a Buy and raises the price target from $162 to $188.